UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

European journal of cancer (1990), 2019-07, Vol.116, p.116-136

2019

Volltextzugriff (PDF)

Occupational exposures in rare cancers: A critical review of the literature

Critical reviews in oncology/hematology, 2014-05, Vol.90 (2), p.99-134

2014

Volltextzugriff (PDF)

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Annals of oncology, 2005-07, Vol.16 (7), p.1152-1159

2005

Volltextzugriff (PDF)

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

Annals of oncology, 2007-05, Vol.18 (5), p.917-924

2007

Volltextzugriff (PDF)

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Annals of oncology, 2011-11, Vol.22 (11), p.2476-2481

2011

Volltextzugriff (PDF)

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia

European journal of cancer (1990), 2014-08, Vol.50 (12), p.2082-2089

2014

Volltextzugriff (PDF)

Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature

Cancer treatment reviews, 2021-11, Vol.100, p.102289-102289, Article 102289

2021

Volltextzugriff (PDF)

Insulin-Like Growth Factor (IGF) family and prostate cancer

Critical reviews in oncology/hematology, 2006-05, Vol.58 (2), p.124-145

2006

Volltextzugriff (PDF)

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors

Annals of oncology, 2013-02, Vol.24 (2), p.322-328

2013

Volltextzugriff (PDF)

Potential drug interactions in elderly cancer patients

Critical reviews in oncology/hematology, 2011-06, Vol.78 (3), p.220-226

2011

Volltextzugriff (PDF)

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors

Annals of oncology, 2002-07, Vol.13 (7), p.1017-1028

2002

Volltextzugriff (PDF)

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

European journal of cancer (1990), 2000-07, Vol.36 (11), p.1389-1394

2000

Volltextzugriff (PDF)

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

British journal of cancer, 2005-10, Vol.93 (8), p.909-914

2005

Volltextzugriff (PDF)

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Annals of oncology, 2005-03, Vol.16 (3), p.411-418

2005

Volltextzugriff (PDF)

Management of Brain Metastases from Germ Cell Tumors: A Single Center Experience

Oncology, 2013-07, Vol.85 (1), p.21-26

2013

Volltextzugriff (PDF)

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

JNCI : Journal of the National Cancer Institute, 2000-01, Vol.92 (1), p.54-61

2000

Volltextzugriff (PDF)

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

Journal of clinical oncology, 1996-10, Vol.14 (10), p.2638-2645

1996

Volltextzugriff (PDF)

Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress?

Annals of oncology, 2000-12, Vol.11 (12), p.1523-1530

2000

Volltextzugriff (PDF)

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3386-3391

1998

Volltextzugriff (PDF)

Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres

Annals of oncology, 2001-09, Vol.12 (9), p.1313-1319

2001

Volltextzugriff (PDF)

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

Annals of oncology, 2000-02, Vol.11 (2), p.151-156

2000

Volltextzugriff (PDF)

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force

Critical reviews in oncology/hematology, 2007-04, Vol.62 (1), p.62-73

2007

Volltextzugriff (PDF)

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

European journal of cancer (1990), 2001-11, Vol.37 (17), p.2194-2198

2001

Volltextzugriff (PDF)

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1641-1648

2001

Volltextzugriff (PDF)

Prognostic factors for survival in patients with brain metastases from renal cell carcinoma

Cancer, 1998-12, Vol.83 (12), p.2548-2553

1998

Volltextzugriff (PDF)

1 – 25 von 185

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(155)

Publikationsform

Artikel
(185)

Sprache

Englisch
(173)
Französisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(183)
Science & Technology
(183)
Humans
(173)
Male
(133)
Adult
(118)
Biological And Medical Sciences
(111)
Medical Sciences
(111)
Middle Aged
(104)
Female
(82)
Aged
(73)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(71)
Chemotherapy
(70)
Pharmacology. Drug Treatments
(68)
Antineoplastic Agents
(60)
Adolescent
(56)
Prognosis
(46)
Cisplatin - Administration & Dosage
(39)
Tumors
(39)
Treatment Outcome
(38)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

Occupational exposures in rare cancers: A critical review of the literature

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)

Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial

Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia

Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature

Insulin-Like Growth Factor (IGF) family and prostate cancer

Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors

Potential drug interactions in elderly cancer patients

Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial

Management of Brain Metastases from Germ Cell Tumors: A Single Center Experience

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables

Chemotherapy in advanced androgen-independent prostate cancer 1990–1999: A decade of progress?

Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors

Non-Hodgkin's lymphoma of the testis: A retrospective study of 84 patients treated in the French anticancer centres

Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials

Organization of the clinical activity of Geriatric Oncology: Report of a SIOG (International Society of Geriatric Oncology) task force

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

Second-Line Chemotherapy in Patients With Relapsed Extragonadal Nonseminomatous Germ Cell Tumors: Results of an International Multicenter Analysis

Prognostic factors for survival in patients with brain metastases from renal cell carcinoma

Aktive Filter

Suchergebnisse filtern